The clinical, preclinical, and basic research of A-CURE focuses primarily on the use of the Impella® heart pump, a transvalvular microaxial flow pump, as the means to unload the heart.
This study shows that presence of CTO in patients with coronary artery disease (CAD) with ischemic heart failure results in adverse long-term prognosis.
